Correction: Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer (Jul, 10.1007/s00330-024-10857-7, 2024)

Anna van der Voort*, Kay J. J. van der Hoogt, Ronni Wessels, Robert-Jan Schipper, Jelle Wesseling, Gabe S. Sonke, Ritse M. Mann

*Corresponding author for this work

Research output: Contribution to journalErratum / corrigendum / retractionsAcademic

Abstract

In the Abstract of this article, subsection Results, the sentence beginning with “In HR-negative/HER2-positive breast cancer…” should have been “In HR-positive/HER2-positive breast cancer…”. The correct sentence is: In HR-positive /HER2-positive breast cancer the NPV for DCE MRI differs between MRI field strength (1.5 T: 50% vs. 3 T: 81% (p = 0.02)). Furthermore, in the online version of the article, In Section ‘Endpoints’ the equation for ADCmean is displayed incorrectly due to an error in copyediting. Instead of: (Formula presented.) The correct equation is as follows: (Formula presented.) The original article has been corrected.

Original languageEnglish
Number of pages1
JournalEuropean Radiology
DOIs
Publication statusPublished - 1 Aug 2024

Fingerprint

Dive into the research topics of 'Correction: Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer (Jul, 10.1007/s00330-024-10857-7, 2024)'. Together they form a unique fingerprint.

Cite this